🇺🇸 FDA
Patent

US 7557081

Alpha-1-acid glycoprotein for the treatment of diabetes

granted A61KA61K38/1709A61K38/28

Quick answer

US patent 7557081 (Alpha-1-acid glycoprotein for the treatment of diabetes) held by Essential Skincare, LLC expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Essential Skincare, LLC
Grant date
Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/1709, A61K38/28, A61P, A61P3/00